These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 986662)

  • 1. Mouse-killing and motor activity: effects of chronic delta9-tetrahydrocannabinol and pilocarpine.
    Miczek KA
    Psychopharmacology (Berl); 1976 May; 47(1):59-64. PubMed ID: 986662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.
    Anderson PF; Jackson DM; Chesher GB; Malor R
    Psychopharmacologia; 1975 Jul; 43(1):31-6. PubMed ID: 1161992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta9-tetrahydrocannabinol induced inhibition of predatory aggression in the rat.
    Kilbey MM; Moore JW
    Psychopharmacologia; 1973 Jul; 31(2):157-66. PubMed ID: 4737311
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic interaction between cannabinol and delta9-tetrahydrocannabinol.
    Takahashi RN; Karniol IG
    Psychopharmacologia; 1975; 41(3):277-84. PubMed ID: 168604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic delta9-tetrahydrocannabinol in rats: effect on social interactions, mouse killing, motor activity, consummatory behavior, and body temperature.
    Miczek KA
    Psychopharmacology (Berl); 1979 Jan; 60(2):137-46. PubMed ID: 106423
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute and chronic effects on rats of (-) 1 -trans-tetrahydrocannabinol on unlearned motor tasks.
    Potvin RJ; Fried PA
    Psychopharmacologia; 1972; 26(4):369-78. PubMed ID: 4674065
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to delta9-tetrahydrocannabinol in adapted and nonadapted rabbits.
    Martin P; Consroe P
    Pharmacol Biochem Behav; 1978 Dec; 9(6):753-8. PubMed ID: 746051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
    Dhawan K; Kumar S; Sharma A
    J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse-killing behavior (muricide) induced by delta 9-tetrahydrocannabinol in the rat.
    Ueki S; Fujiwara M; Ogawa N
    Physiol Behav; 1972 Oct; 9(4):585-7. PubMed ID: 4677621
    [No Abstract]   [Full Text] [Related]  

  • 11. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of delta9-tetrahydrocannabinol on pilocarpine-induced parotid secretions of the rat.
    Nagle B; Tomassone BM; Digregorio J; Piraino A
    Eur J Pharmacol; 1976 Dec; 40(2):337-43. PubMed ID: 991940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment.
    Wu X; French ED
    Neuropharmacology; 2000 Jan; 39(3):391-8. PubMed ID: 10698005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic effects of beta9-tetrahydrocannabinol on seizures in the gerbil.
    Ten Ham M; Loskota WJ; Lomax P
    Eur J Pharmacol; 1975 Mar; 31(1):148-52. PubMed ID: 1126373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol.
    Bhargava HN
    Eur J Pharmacol; 1976 Mar; 36(1):259-62. PubMed ID: 944134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical correlates in mouse-killing behavior of the rat: brain acetylcholine and acetylcholinesterase after administration of delta9-tetrahydrocannabinol.
    Yoshimura H; Fujiwara M; Ueki S
    Brain Res; 1974 Dec; 81(3):567-70. PubMed ID: 4474050
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of the three phases of muricidal behavior induced by delta9-tetrahydrocannabinol in isolated, fasting rats.
    Bac P; Pages N; Herrenknecht C; Paris M
    Physiol Behav; 1998 Mar; 63(5):815-20. PubMed ID: 9618004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to the hypothermic and aggression-attenuating effect of delta 8 - and delta 9 - tetrahydrocannabinol in mice.
    Ten Ham M; De Jong Y
    Eur J Pharmacol; 1974 Sep; 28(1):144-8. PubMed ID: 4473345
    [No Abstract]   [Full Text] [Related]  

  • 20. Delta9-tetrahydrocannabinol and aggressive behavior in rats.
    Miczek KA; Barry H
    Behav Biol; 1974 Jun; 11(2):261-7. PubMed ID: 4858807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.